Light detection action : feasibility of ECL for the monitoring of therapeutic dosage toward personalised medicine

Brown, Kelly and Dennany, Lynn (2021) Light detection action : feasibility of ECL for the monitoring of therapeutic dosage toward personalised medicine. In: 2021 #RSCPoster Twitter Conference, 2021-03-02 - 2021-03-03, Virtual.

[thumbnail of Brown-Dennany-RSC2021-Light-detection-action-feasibility-of-ECL]
Preview
Text (Brown-Dennany-RSC2021-Light-detection-action-feasibility-of-ECL)
Brown_Dennany_RSC2021_Light_detection_action_feasibility_of_ECL.pdf
Final Published Version
License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo

Download (314kB)| Preview
    [thumbnail of Brown-Dennany-RSC2021-Light-detection-action-feasibility-of-ECL]
    Preview
    Image (Brown-Dennany-RSC2021-Light-detection-action-feasibility-of-ECL)
    Brown_Dennany_RSC2021_Light_detection_action_feasibility_of_ECL.png
    License: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 logo

    Download (752kB)| Preview

      Abstract

      Electrochemiluminescence (ECL) has a proven track record for the detection of illicit substances, yet little investigation into its application within medical devices has been witnessed to date. The ability to not only detect therapeutic products such as cancer therapies, but monitor these alongside disease biomarkers will provide the prognostic and diagnostic information required by physicians to begin to construct personalised treatment plans. Here we present an initial feasibility study toward the development of a remote ECL sensor for the monitoring of cancer therapy uptake alongside disease biomarkers to facilitate remote and real-time patient monitoring.

      ORCID iDs

      Brown, Kelly and Dennany, Lynn ORCID logoORCID: https://orcid.org/0000-0002-5481-1066;